OncoSil receives Malaysian regulatory approval
Filed with ASX · · 2 pages · English
Earlier from OncoSil Medical
- Preliminary Final Report - Appendix 4E Announcement
- HDE filing submitted in US for Bile Duct Cancer treatment
- OncoSil presents clinical data at ESMO World Congress
- OncoSil files for TGA registration
- OncoSil receives Singapore regulatory approval
Later from OncoSil Medical
- Investor Update
- Receipt of $2.8m R&D Tax Incentive Refund
- Positive PanCO trial update on resected cohort
- OncoSil achieves first commercial sale
- OncoSil receives Swiss regulatory approval
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical